| UNITED STATES |
| SECURITIES AND EXCHANGE COMMISSION |
| Washington, D.C. 20549 |
| FORM 8-K |
| CURRENT REPORT |
| Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 |
| Date of Report (Date of earliest event reported)May 20, 2014 |
| ONLINE DISRUPTIVE TECHNOLOGIES, INC. |
| (Exact name of registrant as specified in its charter) |
| Nevada | 000-54394 | 27-1404923 |
| (State or other jurisdiction | (Commission File | (IRS Employer |
| of incorporation) | Number) | Identification No.) |
| 3120 S. Durango Dr. Suite 305, Las Vegas, Nevada 89117 |
| (Address of principal executive offices and Zip Code) |
| Registrant's telephone number, including area code:(702) 579-7900 |
| Not Applicable |
| (Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
2
Item 8.01 Other Events.
Our majority owned Israeli subsidiary, Savicell Diagnostic Ltd., has been granted approval of its patent, “METHODS OF MONITORING AND ANALYZING METABOLIC ACTIVITY PROFILES > DIAGNOSTIC AND THERAPEUTIC USES OF SAME” from the United States patent office effective as of May 20, 2014.
The above identified patent application will issue as US Patent No. 8,728,758.
The patent certificate is expected to be received two to three months from issuance.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ONLINE DISRUPTIVE TECHNOLOGIES, INC.
| By:“Giora Davidovits” | |
| Giora Davidovits | |
| President, Chief Executive Officer, Secretary, | |
| Treasurer and Chief Financial Officer | |
| Dated: June 27, 2014 |